Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,437 public trials 2,853 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Not yet recruiting

Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage

NCT07218185

Conditions: Afibrinogenemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +15 more
Locations: Anschutz Medical Center, University of Colorado Aurora, Colorado, United States

Ryder Trauma Center/Jackson Memorial Hospital, University of Miami Miami, Florida, United States

R Adams Cowley Shock Trauma Center, University of Maryland Baltimore, Maryland, United States

Barnes Jewish Hospital, Washington University of Saint Louis St Louis, Missouri, United States

View Trial Details

Not yet recruiting

Prenatal Transplantation for Fetuses With Fanconi Anemia

NCT07408583

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +13 more
Locations: University of California, San Francisco San Francisco, California, United States

Stanford University Stanford, California, United States

View Trial Details

Not yet recruiting

Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2

NCT07650110

Conditions: Brain Diseases, Brain Infarction, Brain Ischemia, +38 more
Locations: Not specified

View Trial Details

Not yet recruiting

Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)

NCT07153497

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

PET-Enabled Dual-Energy CT in Multiple Myeloma

NCT07646873

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: UC Davis EXPLORER Molecular Imaging Center Sacramento, California, United States

View Trial Details

Not yet recruiting

A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

NCT07647029

Conditions: Blood Platelet Disorders, Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT), Breast Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma

NCT07612787

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Centre Hospitalier Universitaire Amiens, France

Centre Hospitalier Universitaire Angers, France

Centre Hospitalier Universitaire Annecy, France

Centre Hospitalier D'Argenteuil Argenteuil, France

View all 30 locations

View Trial Details

Not yet recruiting

CM336-SOC for Dynamically High-Risk Multiple Myeloma Study

NCT07648459

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in MPN Patients

NCT07648433

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not yet recruiting

Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission

NCT07644481

Conditions: AML (Acute Myelogenous Leukemia), Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Hematologic Diseases, +6 more
Locations: Not specified

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions